Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2385242 | 0.98 | HRH3 (0.33) | HRH3 | |
| Bromide SCHEMBL7135727 | 0.96 | HRH3 (0.32) | HRH3 | |
| Hydrochloric Acid SCHEMBL2933737 | 0.96 | HRH3 (0.32) | HRH3 | |
| Iodide SCHEMBL16164054 | 0.93 | GPR84 (0.38) | — | |
| Iodide SCHEMBL16163921 | 0.93 | GPR84 (0.38) | — | |
| SCHEMBL7748878 | 0.91 | HRH3 (0.30) | HRH3 | |
| SCHEMBL13274444 | 0.91 | GPR84 (0.39) | — | |
| SCHEMBL3722775 | 0.91 | GPR84 (0.39) | — | |
| SCHEMBL4235886 | 0.91 | GPR84 (0.39) | — | |
| SCHEMBL16163818 | 0.91 | GPR84 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| US-9598342-B2 | Production of acetic acid with enhanced catalyst stability | CELANESE INTERNATIONAL CORPORATION (US) | 2017-03-21 | — | — | US | disclosed |
| US-20140309455-A1 | PRODUCTION OF ACETIC ACID WITH ENHANCED CATALYST STABILITY | CELANESE INTERNATIONAL CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309455-A1 | PRODUCTION OF ACETIC ACID WITH ENHANCED CATALYST STABILITY | SSTR2, SP1, ADH1C | HRH3 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.